MarketsandMarkets Real-World Evidence and Data Analytics Conference

Real-world data and real-world evidence are poised to keep making strides in 2023. This analysis of clinical evidence studies the usage, potential advantages, and risk of a medical product inferred from real-world data analysis. Real-world evidence (RWE) is accelerating its involvement in the early benefit elucidation of medicinal drugs.

RWE solutions have proven to be extremely useful, as they allow industrial and academic researchers to monitor patients using digitally connected platforms while assisting in the organization and evaluation of clinical data for regulatory submissions. Since RWE research is still in an evolution process and few gaps in the area have been explored, more guidance and a consented annotation are obligatory to increase the effectuation of real-world data.

After five successful editions of the Real-World Evidence and Life Sciences Analytics Conference in Boston, USA, MarketsandMarkets is proud to announce its upcoming Europe edition of the Real-World Evidence and Life Sciences Analytics Conference to be held on October 5th–6th, 2023, in Frankfurt, Germany. The conference will bring together the full spectrum of experts, leaders, and stakeholders to share their perspectives on significant points and hold discussions on the best practices, with a key takeaway being better decision-making.